Search Results for: ARL13B

134 interactions involving ARL13B - ADP ribosylation factor like GTPase 13B found:

Sort by: Symbol Number of Pathways Number of Drugs Number of Diseases
Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
PLPPR2 phospholipid phosphatase related 2
  • Lysosphingolipid and LPA receptors
PMP22 peripheral myelin protein 22
  • EGR2 and SOX10-mediated initiation of Schwann cell myelination
  • Charcot-Marie-Tooth disease (CMT); Hereditary motor and sensory neuropathy; Peroneal muscular atrophy
PRB1 proline rich protein BstNI subfamily 1
PTPN9 protein tyrosine phosphatase non-receptor type 9
  • Interleukin-37 signaling
RTP2 receptor transporter protein 2
  • Olfactory Signaling Pathway
S100A2 S100 calcium binding protein A2
  • Olopatadine
  • Calcium
  • Zinc
  • Copper
  • Zinc acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
SACM1L SAC1 like phosphatidylinositide phosphatase
  • Synthesis of PIPs at the ER membrane
  • Synthesis of PIPs at the Golgi membrane
SEMA4G semaphorin 4G
SLC13A3 solute carrier family 13 member 3
  • Sodium-coupled sulphate, di- and tri-carboxylate transporters
SLC2A5 solute carrier family 2 member 5
  • Neutrophil degranulation
  • Intestinal hexose absorption
SLC35A1 solute carrier family 35 member A1
  • Sialic acid metabolism
  • Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F)
  • Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F)
  • Transport of nucleotide sugars
  • Congenital disorders of glycosylation (CDG) type II
SLC35B1 solute carrier family 35 member B1
SLC38A7 solute carrier family 38 member 7
SLC39A2 solute carrier family 39 member 2
  • Zinc influx into cells by the SLC39 gene family
SMAGP small cell adhesion glycoprotein
SPN sialophorin
  • Cell surface interactions at the vascular wall
  • Basigin interactions
STRIT1 small transmembrane regulator of ion transport 1
STX1A syntaxin 1A
  • Serotonin Neurotransmitter Release Cycle
  • Norepinephrine Neurotransmitter Release Cycle
  • Glutamate Neurotransmitter Release Cycle
  • Dopamine Neurotransmitter Release Cycle
  • Acetylcholine Neurotransmitter Release Cycle
  • Insulin processing
  • Regulation of insulin secretion
  • Other interleukin signaling
  • Toxicity of botulinum toxin type C (botC)
  • LGI-ADAM interactions
  • Neurexins and neuroligins
  • GABA synthesis, release, reuptake and degradation
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
STX7 syntaxin 7
TECR trans-2,3-enoyl-CoA reductase
  • Synthesis of very long-chain fatty acyl-CoAs

Page 5 out of 7 pages